Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/18/17 → 4/18/20 |
Funding
- PRA Health Sciences (GS-US-384-1944 // GS-US-384-1944)
- Gilead Sciences, Inc (GS-US-384-1944 // GS-US-384-1944)
Prot# GS-US-384-1944: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)
- Rinella, Mary Eugenia (PD/PI)
Project: Research project